Phosphorylation of RPS6 at Ser235 and Il-6 Release Emerge as Components of a Peripheral Inflammatory Signature in Parkinson’s Disease Manifestation
This study identifies phosphorylation of ribosomal protein S6 at Ser235 and increased IL-6 release in peripheral blood mononuclear cells as a distinct inflammatory signature that correlates with clinical severity and distinguishes manifesting Parkinson's disease from non-manifesting states across both idiopathic and LRRK2-associated forms.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
The Big Picture: Parkinson's is a Body-Wide Issue
For a long time, scientists thought Parkinson's disease (PD) was just a problem happening inside the brain, like a factory breaking down in one specific room. This study suggests that's only half the story. The researchers found that the "factory workers" in the rest of the body—specifically the immune cells in our blood—are also acting strangely when someone has Parkinson's.
They wanted to find a way to tell the difference between people who carry a genetic risk for Parkinson's but don't have symptoms yet, and those who do have symptoms. They looked for a "smoke signal" in the blood that tells us the disease has officially started.
The Cast of Characters
To solve this mystery, the team gathered blood samples from four different groups of people:
- Healthy Controls: People with no Parkinson's and no genetic risk.
- The "Silent Carriers": People who have a specific genetic mutation (called LRRK2) that causes Parkinson's, but they are currently healthy and have no symptoms.
- The "Symptomatic Carriers": People with that same LRRK2 mutation who do have Parkinson's symptoms.
- The "Idiopathic" Group: People with Parkinson's who do not have the specific LRRK2 mutation (this is the most common type of Parkinson's).
The Investigation: Looking for the "Smoke Signals"
The researchers used a high-tech microscope (mass spectrometry) to look at the proteins in these blood cells. They were looking for two main things:
- Proteins: The building blocks of the cell.
- Phosphorylation: Think of this as a "switch" or a "highlighter" that turns proteins on or off. When a protein gets phosphorylated, it changes how the cell behaves.
Discovery 1: The "Ribosome" Factory is Revved Up
Inside every cell, there are tiny machines called ribosomes. Their job is to build new proteins, like a 3D printer.
- What they found: In people who had symptoms (both the genetic carriers and the non-genetic patients), these ribosome machines were "switched on" and working overtime. Specifically, a switch on a part of the machine called RPS6 (at a spot named Ser235) was flipped high.
- The Analogy: Imagine a car engine. In healthy people and "silent carriers," the engine is idling quietly. In people with active Parkinson's, the engine is revving loudly.
- The Key Difference: The "silent carriers" (who have the gene but no symptoms) did not have this revving engine. This suggests that the "revving" is what marks the transition from "at risk" to "sick."
Discovery 2: The "Fire Alarm" (IL-6)
The researchers also checked if the blood cells were releasing inflammatory chemicals.
- What they found: The blood cells from people with active Parkinson's (especially the non-genetic type) were screaming "Fire!" They released huge amounts of a chemical called IL-6, which is a signal for inflammation.
- The Analogy: If the ribosome is the engine, IL-6 is the smoke. The "silent carriers" had a little bit of smoke, but the symptomatic patients were blowing thick black smoke.
The "Aha!" Moment: It's Not Just the Gene
One of the most surprising findings was about the LRRK2 gene.
- Scientists thought that because the LRRK2 gene is a "kinase" (a type of enzyme that flips switches), it was directly flipping the RPS6 switch.
- The Test: They used a drug to turn off the LRRK2 gene's activity.
- The Result: Turning off LRRK2 stopped some other switches, but it did not stop the RPS6 switch from being revved up.
- The Meaning: The "revving" of the ribosome and the "smoke" (IL-6) are happening because of the disease process itself, not just because of the specific genetic mutation. It's a general feature of having the disease, regardless of whether you have the gene or not.
Connecting the Dots: Blood Cells Talking to the Brain
The researchers wanted to know if this "revving" in the blood could actually affect the brain.
- The Experiment: They took the liquid (conditioned media) from the blood cells of Parkinson's patients and dripped it onto mouse brain cells (astrocytes) in a dish.
- The Result: The mouse brain cells immediately started revving their own RPS6 engines.
- The Analogy: It's like the immune cells in the blood are shouting instructions to the brain cells, and the brain cells are listening and changing their behavior. This suggests that the inflammation in the body might be helping to drive the disease in the brain.
What This Means for Patients
The study concludes that looking at the blood for these two specific things—the RPS6 switch being flipped and high levels of IL-6—can tell you if a person has moved from "at risk" to "actively sick."
- Correlation with Severity: The more "revved up" the RPS6 switch was, the worse the patient's symptoms were (both movement and thinking problems).
- A New Tool: This gives doctors a potential new way to measure how bad the disease is and to track if a treatment is working, by simply looking at a blood sample.
Summary in One Sentence
This study found that when Parkinson's disease becomes active, the immune cells in the blood start revving their protein-making engines and shouting inflammatory signals, a change that happens in both genetic and non-genetic patients and seems to talk directly to the brain to worsen the disease.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.